We are live on
!
Find out more
FRM
Fox Run Management Portfolio holdings
AUM
$572M
1-Year Est. Return
24.16%
This Fund
S&P 500
This Quarter
Est. Return
+9.22%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$124M
AUM Growth
+$14.4M
(+13%)
Cap. Flow
+$8.49M
Cap. Flow
% of AUM
6.84%
Top 10 Holdings %
Top 10 Hldgs %
8.4%
Holding
601
New
263
Increased
50
Reduced
50
Closed
238
Top Buys
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.25M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.25M |
| 3 |
Haemonetics
HAE
|
+$779K |
| 4 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$759K |
| 5 |
GoDaddy
GDDY
|
+$694K |
Top Sells
| 1 |
Pfizer
PFE
|
+$858K |
| 2 |
DXC Technology
DXC
|
+$821K |
| 3 |
West Pharmaceutical
WST
|
+$728K |
| 4 |
Southwest Airlines
LUV
|
+$717K |
| 5 |
Howmet Aerospace
HWM
|
+$650K |
Sector Composition
| 1 | Technology | 15.52% |
| 2 | Industrials | 13.79% |
| 3 | Consumer Discretionary | 12.99% |
| 4 | Healthcare | 11.5% |
| 5 | Financials | 9.7% |
Similar funds
MAM
NA
EHI
MW
BSG
RI
XI
TWA
Fox Run Management's Q4 2019 Portfolio in Review
As of Q4 2019, Fox Run Management held 601 positions worth $124M, up 13% from $110M the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Fox Run Management deployed $8.49M of net new capital in Q4 2019, opening 263 new positions and adding to 50 existing holdings. Its largest new stake was Haemonetics: 6,441 shares worth $740K.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Generac Holdings, an estimated $629K trimmed.
- Fox Run Management's largest Q4 2019 buy was Haemonetics: 6,441 shares worth $740K.
- Fox Run Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $1.25M increase.
- Fox Run Management's biggest Q4 2019 reduction was Generac Holdings, cutting an estimated $629K.
- Fox Run Management fully exited Pfizer in Q4 2019, selling an estimated $858K.
- Fox Run Management's ten largest holdings make up 8.4% of its $124M portfolio in Q4 2019.
- Fox Run Management opened 263 new positions and closed 238 in Q4 2019.
- Fox Run Management's portfolio value rose 13% quarter-over-quarter to $124M.
Based on Fox Run Management's 13F filing for Q4 2019, filed 14 Feb 2020.